AQV-28962-77601
3 vaccinations
2 coded responses
16 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 060 / CT
- Registered
- 2021-09-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-10
Registered in v-safe
-
2021-09-10
Dose 1 — Moderna
-
2021-09-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-12
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: Pain, Redness · Fatigue or tirednessFree text: Bruising at injection site- larger than a quarterMedDRA releases: 2024-11 · check-in free text available
- 2021-09-13
- 2021-09-17
-
2021-09-24
Survey response — day 14, dose 1MedDRA: Injection site reaction, Rash erythematous, Rash pruritic — Feeling: GoodFree text: Rash at injection site for several days. Red and itchy.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
-
2021-10-08
Dose 2 — ModernaCo-administered: Do not remember
- 2021-10-08
-
2021-10-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-12
- 2021-10-13
- 2021-10-17
- 2021-10-22
- 2021-10-31
- 2021-11-19
-
2022-03-08
Dose 3 — Moderna
-
2022-03-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · Fever · Headache, Joint painsAdult check-in
- 2022-09-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-10 | Moderna | No |
| 2 | 2021-10-08 | Moderna | Do not remember |
| 3 | 2022-03-08 | Moderna | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Bruising at injection site- larger than a quarter
Release 9 — day 14, dose 1
Symptoms: Rash at injection site for several days. Red and itchy.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site reaction | · | · | ✓ |
| SD | Rash erythematous | · | · | ✓ |
| SD | Rash pruritic | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release